Healthy Subjects Clinical Trial
Official title:
Effects of Transcranial Direct Current Stimulation Associated With Physical Exercise: a Metaplasticity Study
This study aims to understand metaplasticity through the association of transcranial direct current stimulation (tDCS) and physical exercise. For this purpose, the study will be separate in 2 phases: in the first phase the aim is verify the effects of physical exercise on cortical excitability. After this 1st phase two intensities of physical exercise will be chosen for the second phase. In the 2nd phase, subjects will undergo to anodal, cathodal and sham tDCS plus physical exercise.
Before the two phases of the study, the subjects will be evaluate in the following aspects:
anxiety by the beck anxiety inventory; depression by the beck depression inventory; level of
physical exercise by the international physical activity questionnaire; stress by the stress
perceived scale 10.
In the first phase, the subjects will be undergo to 4 conditions: (i) 15 minutes of physical
exercise with moderate intensity; (ii) 10 minutes of physical exercise with high intensity;
(iii) 30 minutes of physical exercise with mild intensity; (iv) 15 or 30 minutes of rest.
Before each condition, cortical excitability will be measure through the Transcranial
magnetic stimulation by motor evoked potential (MEP); the blood glucose level will be
evaluate by glucometer. The MEP also will be done immediately after the physical exercise and
in every 5 min for 30 after the end of exercise/rest. The blood glucose level will be done
immediately after the exercise..
In the second phase, the subjects will be undergo to 6 conditions: (i) anodal tDCS + physical
exercise 1; (ii) anodal tDCS + physical exercise 2; (iii) cathodal tDCS + physical exercise
1; (iv) cathodal tDCS + physical exercise 2; (v) sham tDCS + physical exercise 1; (vi) sham
tDCS + physical exercise 2. The intensity and time of physical exercise depends of the
results of the previous phase and will be determine after the end of phase 1. In this phase,
the blood glucose level will be evaluate before and immediately the physical exercise. The
cortical excitability will be evaluate through the Transcranial magnetic stimulation by the
following measures: motor evoked potential - before the tDCS,after tDCS, immediately , 10,
20, 30, 60, 90 minutes after the exercise; resting motor threshold - before tdcs, immediately
and 90 minutes after the exercise; recruitment curve - before tdcs, immediately and 90
minutes after the exercise.
tDCS condition During tDCS application, patients will be seated in a comfortable chair with
head and arms rests. Current will be applied by a DC stimulator (NeuroConn, Germany) using a
pair of saline-soaked sponge electrodes (surface 35 and 36cm²).
tDCS will be applied to Cz and Oz according to International 10-20 EEG system. In the anodal
tDCS, the anode will be placed in Cz and cathode in Oz. In the cathodal tDCS the inverse
position will be done. Parameters of current intensity and duration (dose) used were
previously established in poststroke patients: 2 mA stimulation intensity for 20 minutes with
current ramping up and down of 10 seconds each.
Sham tDCS has been used in several studies to evaluate the effect of active tDCS. For sham,
the same position of anodal tDCS will be assumed, however, current duration is only 30
seconds, with current ramping up and down of 10 seconds each. Moreover, the
electrostimulation device is automatically turned off without patient's perception. Thus,
patients experience early sensations (mild to moderate tingling) in stimulation site without
inducing effect. Moreover, after each tDCS session, patients will answer adverse effects
questionnaire.
Physical exercise condition The intensity of physical exercise will be determine by the
maximum heart rate (max HR) using the formula (220 - age). For the high intensity, the
intensity will between xx and xx% of maxHR; moderate intensity, 64-76% of maxHR; mild
intensity, 57-63% of maxHR. Furthermore, during the physical exercise the heart rate will be
continuous evaluate by the POLAR and the rate perceived scale will be register in each 3
minutes by the modified Borg scale Outcome measures Evaluation of brain activity will be
performed using single-pulse transcranial magnetic stimulation (TMS-p). Magnetic stimulation
(Neurosoft, Russia) will be applied through a figure-8 coil to determine motor cortex
representation of right tibial anterior muscle (hotspot) and performed the following
electrophysiological measures to assess cortical activity: (i) Motor Evoked Potential (MEP);
(ii) resting motor threshold (RMT) and (iii) Recruitment curve (RC).
Firstly, patients will be instructed to sit in a chair and to search a comfortable position.
The hotspot will be considered the most excitable area, with more intense motor evoked
potential (MEP), measured by electromyography.
The following electrophysiological measures will be performed in left cerebral hemisphere to
assess cortical activity:
(i) Motor Evoked Potential (MEP) : the intensity of magnetic stimulator is adjusted to
produce an average MEP of 0.4 mV. TMS-p will be applied in the area of cortical
representation of the tibial anterior and mean responses to stimuli should reach 0.4 to 0.6
mV.
(ii) Resting motor threshold (RMT) : will be request to the patient to perform contraction of
the tibial anterior muscle and then, will be given ten pulses by TMS-p to determinate resting
motor threshold. Motor threshold corresponds to the lowest intensity of TMS-p to produce a
MEP of 50μV in 50% of the pulses applied to the hotspot.
(iii) Recruitment curve (RC): Five stimuli were applied at each of the following intensities:
5% below resting motor threshold (RMT), RMT, 5% above RMT, 10% above RMT, 20% above RMT, 30%
above RMT, 35% above RMT and at 100% of stimulator output. The five stimuli at each intensity
were delivered in a block, but the order of stimulation intensity changes was random. The
interval between successive TMS stimuli was between 5.5 to 6.5 s.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05483998 -
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
|
Phase 1 | |
| Recruiting |
NCT02417714 -
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
|
||
| Recruiting |
NCT02235012 -
Cognitive Biases Under Ketamine
|
N/A | |
| Completed |
NCT04418973 -
Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
|
N/A | |
| Completed |
NCT05088343 -
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
|
Phase 1 | |
| Not yet recruiting |
NCT06248801 -
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
|
Phase 1 | |
| Terminated |
NCT04068259 -
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03279302 -
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
|
Phase 1 | |
| Not yet recruiting |
NCT06233162 -
Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
|
Phase 1 | |
| Recruiting |
NCT04159844 -
Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects
|
N/A | |
| Completed |
NCT06137911 -
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
|
Phase 1 | |
| Completed |
NCT04849286 -
Measurement of HTL0016878 in Cerebrospinal Fluid
|
Phase 1 | |
| Not yet recruiting |
NCT06233227 -
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
|
Phase 1 | |
| Completed |
NCT04096157 -
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
|
Phase 1 | |
| Completed |
NCT01200368 -
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
|
Phase 3 | |
| Recruiting |
NCT05805033 -
Peri-Implant Soft Tissue Integration in Humans: Influence of Material
|
N/A | |
| Completed |
NCT04027803 -
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®
|
Phase 1 | |
| Recruiting |
NCT03467880 -
Multicenter Study of Impulse Oscillometry in Chinese
|
N/A | |
| Completed |
NCT02903095 -
Single Ascending Dose Study of TD-1439 in Healthy Subjects
|
Phase 1 | |
| Active, not recruiting |
NCT02341508 -
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
|
Phase 1 |